Demonstrating Unprecedented Efficacy in Oncology and Neurobiology, Peptide C105Y TFA Exhibits Exquisite Potential in the Combat Against Malignancies and Neurodegenerative Pathologies. Empowering Anti-tumor Mechanisms while Facilitating Cellular Viability, this Synthetic Peptide Propels Therapeutic Advances, Paving the Way for Optimal Management of Diverse Neoplastic Entities and Central Nervous System Disorders.
CAT# | GR2178 |
M.F/Formula | C99H149F3N20O25S |
M.W/Mr. | 2108.42 |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
Caprooyl tetrapeptide-3, an anti-wrinkle peptide, a reaction product of caproic acid and tetrapeptide-3, compris ...
The peptide Difopein, designed, isolated and identified by Haian Fu, is a high affinity inhibitor of 14-3-3 pro ...
GLP-1 is a 30 amino acid peptide (molecular weight of 3297.5) secreted by intestinal L-cells in response to meal ingestion wi ...
ProTx II, a 30-amino acid, disulfide-rich peptide toxin, isolated from the venom of the tarantula, Thrixopelma ...
The peptide st-Ht31 P, A-kinase anchoring protein (AKAP) inhibitor, has the negative control for st-Ht31. In DRG ...